CFB
BMY icon

Cullen/Frost Bankers’s Bristol-Myers Squibb BMY Stock Holding History

Cullen/Frost Bankers’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.23M Sell
56,089
-127,141
-69% -$7.3M 0.03% 248
2026
Q1 		$11.1M Buy
183,230
+24,001
+15% +$1.4M 0.13% 156
2025
Q4 		$8.59M Buy
159,229
+1,921
+1% +$92.4K 0.09% 176
2025
Q3 		$7.09M Buy
157,308
+15,704
+11% +$733K 0.08% 184
2025
Q2 		$6.55M Buy
141,604
+107,394
+314% +$5.27M 0.08% 186
2025
Q1 		$2.09M Buy
34,210
+4,742
+16% +$276K 0.03% 246
2024
Q4 		$1.67M Sell
29,468
-954
-3% -$53.3K 0.02% 255
2024
Q3 		$1.57M Sell
30,422
-8,534
-22% -$400K 0.02% 259
2024
Q2 		$1.62M Sell
38,956
-125,153
-76% -$5.6M 0.02% 256
2024
Q1 		$8.9M Sell
164,109
-116,578
-42% -$5.94M 0.13% 161
2023
Q4 		$14.4M Sell
280,687
-40,307
-13% -$2.12M 0.23% 109
2023
Q3 		$18.6M Sell
320,994
-5,616
-2% -$344K 0.32% 83
2023
Q2 		$20.9M Sell
326,610
-4,166
-1% -$279K 0.35% 74
2023
Q1 		$22.9M Sell
330,776
-4,026
-1% -$284K 0.42% 66
2022
Q4 		$24.1M Buy
334,802
+54,151
+19% +$4.08M 0.46% 63
2022
Q3 		$20M Buy
280,651
+15,235
+6% +$1.11M 0.46% 59
2022
Q2 		$20.5M Buy
265,416
+10,281
+4% +$783K 0.46% 61
2022
Q1 		$18.7M Buy
255,135
+13,151
+5% +$883K 0.36% 74
2021
Q4 		$15.1M Buy
241,984
+4,181
+2% +$245K 0.29% 85
2021
Q3 		$14.1M Buy
237,803
+5,049
+2% +$333K 0.28% 91
2021
Q2 		$15.6M Buy
232,754
+2,810
+1% +$183K 0.31% 82
2021
Q1 		$14.5M Buy
229,944
+724
+0.3% +$45K 0.32% 86
2020
Q4 		$14.2M Sell
229,220
-5,205
-2% -$320K 0.33% 83
2020
Q3 		$14.1M Sell
234,425
-6,757
-3% -$407K 0.35% 79
2020
Q2 		$14.2M Buy
241,182
+10,796
+5% +$646K 0.37% 72
2020
Q1 		$12.8M Buy
230,386
+6,984
+3% +$427K 0.45% 65
2019
Q4 		$14.3M Buy
223,402
+123,552
+124% +$7.08M 0.39% 81
2019
Q3 		$5.06M Buy
99,850
+8,406
+9% +$395K 0.15% 142
2019
Q2 		$4.15M Buy
91,444
+5,711
+7% +$266K 0.13% 152
2019
Q1 		$4.09M Sell
85,733
-3,234
-4% -$161K 0.13% 154
2018
Q4 		$4.63M Sell
88,967
-8,893
-9% -$478K 0.17% 137
2018
Q3 		$6.08M Sell
97,860
-30,261
-24% -$1.8M 0.19% 131
2018
Q2 		$7.09M Sell
128,121
-49,686
-28% -$2.68M 0.22% 119
2018
Q1 		$11.2M Sell
177,807
-30,344
-15% -$1.95M 0.33% 99
2017
Q4 		$12.8M Sell
208,151
-8,413
-4% -$526K 0.4% 88
2017
Q3 		$13.8M Sell
216,564
-10,313
-5% -$602K 0.45% 78
2017
Q2 		$12.6M Sell
226,877
-158,725
-41% -$8.64M 0.42% 82
2017
Q1 		$21M Sell
385,602
-9,350
-2% -$513K 0.72% 49
2016
Q4 		$23.1M Buy
394,952
+10,936
+3% +$598K 0.79% 39
2016
Q3 		$20.7M Buy
384,016
+15,056
+4% +$967K 0.74% 41
2016
Q2 		$27.1M Buy
368,960
+368
+0.1% +$26K 1.01% 19
2016
Q1 		$23.5M Buy
368,592
+7,487
+2% +$472K 0.88% 30
2015
Q4 		$24.8M Buy
361,105
+467
+0.1% +$30.9K 0.94% 28
2015
Q3 		$21.4M Buy
360,638
+15,672
+5% +$994K 0.85% 34
2015
Q2 		$23M Sell
344,966
-7,402
-2% -$488K 0.85% 31
2015
Q1 		$22.7M Sell
352,368
-2,843
-0.8% -$178K 0.85% 30
2014
Q4 		$21M Buy
355,211
+4,933
+1% +$278K 0.81% 34
2014
Q3 		$17.9M Buy
350,278
+1,309
+0.4% +$65.4K 0.73% 41
2014
Q2 		$16.9M Buy
348,969
+6,768
+2% +$334K 0.68% 44
2014
Q1 		$17.8M Buy
342,201
+10,663
+3% +$567K 0.76% 34
2013
Q4 		$17.6M Buy
331,538
+48,407
+17% +$2.47M 0.78% 34
2013
Q3 		$13.1M Buy
283,131
+128,008
+83% +$5.62M 0.64% 46
2013
Q2 		$6.93M Buy
+155,123
New +$6.73M 0.36% 94

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Cullen/Frost Bankers's BMY Position: Q2 2026 in Review

Cullen/Frost Bankers reduced its Bristol-Myers Squibb (BMY) stake by 69% in Q2 2026, selling an estimated $7.3M and leaving 56,089 shares worth $3.23M. The position accounts for 0.03% of the portfolio, ranked #248.

Cullen/Frost Bankers first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $27.1M in Q2 2016. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Cullen/Frost Bankers held 56,089 shares of Bristol-Myers Squibb worth $3.23M as of Q2 2026.
  • Cullen/Frost Bankers sold 127,141 Bristol-Myers Squibb shares in Q2 2026, an estimated $7.3M.
  • Bristol-Myers Squibb made up 0.03% of Cullen/Frost Bankers's portfolio in Q2 2026, its #248 holding.
  • Cullen/Frost Bankers first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Cullen/Frost Bankers's Bristol-Myers Squibb position peaked at $27.1M in Q2 2016.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.